Auto Tyres and rubber tubes company, Ceat surged as much as 9.5 per cent in Friday’s trade on reporting Q1FY19 results. On Friday, the stock bounced back very sharply, breaching its two prior resistances at 1327 followed by 1351, supported by spurt in volumes and 14-period RSI crossing 55 levels.

Larson & Toubro Heavy Engineering have won prestigious orders of Rs. 1,600 crore which will be executed at L&T's fully integrated, advanced coastal manufacturing facility in Hazira, Gujarat. The stock has gained 2 per cent in the first half of trading session on Friday.

The company’s EBITDA for the quarter rose by 36.6 per cent yoy to Rs. 1,281.42 crore with a corresponding margin expansion of 124 bps. EBITDA margin for the quarter remained flat at 17.3 per cent. The PAT for the quarter came in at Rs. 1,115.23 crore, yoy increase of 20.7 per cent.

Sterlite Technologies, an end-to-end global digital network company, posted its financial results for the first quarter ended June 30, 2018. The company’s standalone revenue for the quarter came in at Rs. 876.89 crore, registering 17.8 per cent yoy increase.

Jubilant Foodworks, a master franchise of Domino’s Pizza and Dunkin Donuts brands, surged nearly 5.5 per cent on Friday at 12:00 hours, hitting a significant new all-time high. The stock of Jubilant surged with expectation of posting positive topline and bottomline in its Q1FY19 earnings report.

The company's West Africa division bags a repeat order for 147 buses following which the stock was buzzing on Friday with more than 3 per cent gain. The stock is witnessing a trend reversal after falling for two consecutive days.

Following stocks are close to their 52-week low as at 12.21 p.m. on July 20, 2018.

The markets on July 20, 2018 opened up. BSE Sensex is trading at 36,546.13, up by 194.90 points and the Nifty is trading at 11,015.35, up by 58.25 points. 

Zydus Cadila has received final approval from the USFDA to market Spironolactone Tablets USP (US RLD - Aldactone Tablets). The strength of the said tablets is of 25 mg, 50 mg and 100 mg. The drug will be manufactured at the group’s manufacturing facility at Baddi.

In recent times, you might have heard that consumption story is a good bet, invest in these funds, pharma funds seems to be promising and what not. But what are these sectoral funds? And do they suit every investor?